Vimarsana
Biggest News Aggregation in the World

Page 39 - Oral Solution News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Oral Solution. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Oral Solution Today - Breaking & Trending Today

Global Gaucher Disease Treatment Market to Grow at ~5% CAGR - Vimarsana News

Global Gaucher Disease Treatment Market to Grow at ~5% CAGR

Key Companies Covered in the Global Gaucher Disease Treatment Market Research Report by Kenneth Research are AVROBIO, Inc., Bristol-Myers Squibb Company,...

Letters and medicine recalls sent to healthcare professionals in June 2022 - Vimarsana News

Letters and medicine recalls sent to healthcare professionals in June 2022

A summary of recent letters and notifications sent to healthcare professionals about medicines.

Source: gov.uk
CVS Oral Solution recalled nationwide due to microbial contamination - Vimarsana News

CVS Oral Solution recalled nationwide due to microbial contamination

The U.S. Food and Drug Administration has announced the voluntary recall of a CVS oral solution due to a lot of the product containing harmful bacteria.

Source: wtkr.com
CMP Pharma, Inc Announces that Norliqva®, the First and Only FDA-approved Liquid Solution of Amlodipine, is Now Available - Vimarsana News

CMP Pharma, Inc Announces that Norliqva®, the First and Only FDA-approved Liquid Solution of Amlodipine, is Now Available

/PRNewswire/ -- CMP Pharma announced today that Norliqva® (Amlodipine) Oral Solution, 1 mg/mL, the first and only FDA-approved oral liquid solution of the...

QOL Medical, LLC Selects Optum Frontier Therapies as an Exclusive Pharmacy Partner to Best Support Congenital Sucrase-Isomaltase Deficiency (CSID) Patients on Sucraid® (sacrosidase) Oral Solution - Vimarsana News

QOL Medical, LLC Selects Optum Frontier Therapies as an Exclusive Pharmacy Partner to Best Support Congenital Sucrase-Isomaltase Deficiency (CSID) Patients on Sucraid® (sacrosidase) Oral Solution

/PRNewswire/ -- QOL Medical, LLC, a ground-breaking rare disease pharmaceutical company, announced today it has selected Optum Frontier Therapies as its new...